Search results
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 38 minutes agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 11 hours agoThe drug, which recently completed midstage testing, is in development for Wet AMD, as well as...
Merck to Acquire EyeBio
Morningstar· 12 hours ago“We continue to execute on our science-led business development strategy to expand and diversify our pipeline,” said Dr. Dean Y. Li, president, Merck Research ...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 14 hours agoDigital innovations like M-Trace® bring us one step closer to making the lab of the future a...
The Public Health Community Must Tell the Whole Measles Story
Time via Yahoo News· 2 hours agoOver the first half of the 20th century, the development of an immune globulin for serious cases and...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 1 day agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
Vaccines Fast Facts – KION546
KION 46 Salinas· 4 hours agoThe Centers for Disease Control and Prevention (CDC) provides vaccine recommendations by age, as well as by disease. For more than 100 years, there has...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 8 hours agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Dame Kate Bingham hails ‘astonishing’ deal as start-up sells for $3bn
The Telegraph via Yahoo Finance· 9 hours agoA London biotech business co-founded by Britain’s Covid vaccine tsar Kate Bingham has been bought...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 1 day agoModerna and Merck are evaluating mRNA-4157 in two pivotal late-stage studies for melanoma and...
